Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
Yale New Haven Hospital Emergency Department, New Haven, Connecticut, United States
Qazvin university of medical science, Qazvin, Iran, Islamic Republic of
Washington University School of Medicine, Saint Louis, Missouri, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
University of Utah Medical Center, Salt Lake City, Utah, United States
Sainte Justine Hospital, Montreal, Quebec, Canada
Hopital Louis Mourier, Colombes, France
School of Psychology, University of Cardiff, Cardiff, United Kingdom
Institute of Psychiatry, King's College London, London, Greater London, United Kingdom
University of Manchester (Dept of Neuropyschiatry), Manchester, United Kingdom
Service de Psychiatrie Adulte, Programme dépression, Geneva, Switzerland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.